{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:21:13Z","timestamp":1790065273939,"version":"4.0.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.abd.2022.08.005","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T16:36:09Z","timestamp":1674232569000},"page":"141-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dermatological manifestations of hematologic neoplasms. Part II: nonspecific skin lesions\/paraneoplastic diseases"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3943-3036","authenticated-orcid":false,"given":"Patricia Karla","family":"de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7701-3198","authenticated-orcid":false,"given":"Rafael Oliveira","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-5531","authenticated-orcid":false,"given":"Let\u00edcia Siqueira","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-8586","authenticated-orcid":false,"given":"Mariana Dias","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2022.08.005_bib0005","doi-asserted-by":"crossref","first-page":"09","DOI":"10.1590\/S0365-05962013000100001","article-title":"Paraneoplastic cutaneous manifestations: concepts and updates","volume":"88","author":"Silva","year":"2013","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5826\/dpc.0803a09","article-title":"Obligate and facultative paraneoplastic dermatoses: an overview","volume":"8","author":"Caccavale","year":"2018","journal-title":"Dermatol Pract Concept."},{"key":"10.1016\/j.abd.2022.08.005_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-4632.2005.02668.x","article-title":"Mucocutaneous paraneoplastic syndromes in hematologic malignancies","volume":"45","author":"Zappasodi","year":"2006","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.blre.2017.07.003","article-title":"The skin as a window to the blood: cutaneous manifestations of myeloid malignancies","volume":"31","author":"Li","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.abd.2022.08.005_bib0025","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jaad.2006.07.016","article-title":"From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research","volume":"55","author":"Wallach","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40257-020-00553-9","article-title":"Immune-mediated dermatoses in patients with haematological malignancies: a comprehensive review","volume":"21","author":"Maglie","year":"2020","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-017-8621-8","article-title":"A comprehensive review of neutrophilic diseases","volume":"54","author":"Marzano","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.abd.2022.08.005_bib0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40257-018-00418-2","article-title":"Neutrophilic dermatoses associated with myeloid malignancies","volume":"20","author":"Lepelletier","year":"2019","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0045","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/jid.2012.408","article-title":"Evidence of differentiation in myeloid malignancies associated neutrophilic dermatosis: a fluorescent in situ hybridization study of 14 patients","volume":"133","author":"Sujobert","year":"2013","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0050","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13074","article-title":"Neutrophilic dermatoses as adverse effects of checkpoint inhibitors: a review","volume":"32","author":"Ravi","year":"2019","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.abd.2022.08.005_bib0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaad.2013.06.023","article-title":"Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients","volume":"69","author":"Rochet","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0060","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3892\/ijo.2013.1874","article-title":"Insight into Sweet\u2019s syndrome and associated-malignancy: a review of the current literature","volume":"42","author":"Raza","year":"2013","journal-title":"Int J Oncol."},{"key":"10.1016\/j.abd.2022.08.005_bib0065","series-title":"In: Weedon\u2019s Skin Pathology","first-page":"195","article-title":"The vasculopathic reaction pattern","author":"Weedon","year":"2010"},{"key":"10.1016\/j.abd.2022.08.005_bib0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jamadermatol.2016.6092","article-title":"Clinicopathologic, immunohistochemical, and molecular features of histiocytoid Sweet syndrome","volume":"153","author":"Alegr\u00eda-Landa","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0075","doi-asserted-by":"crossref","first-page":"e3033","DOI":"10.1097\/MD.0000000000003033","article-title":"Histiocytoid Sweet syndrome is more frequently associated with myelodysplastic syndromes than the classical neutrophilic variant","volume":"95","author":"Ghoufi","year":"2016","journal-title":"Medicine."},{"key":"10.1016\/j.abd.2022.08.005_bib0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00128071-200203020-00005","article-title":"Sweet\u2019s syndrome","volume":"3","author":"Cohen","year":"2002","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0085","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco","year":"2009","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2022.08.005_bib0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7861\/clinmedicine.19-3-224","article-title":"Pyoderma gangrenosum \u2013 a guide to diagnosis and management","volume":"19","author":"George","year":"2019","journal-title":"Clin Med."},{"key":"10.1016\/j.abd.2022.08.005_bib0095","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaad.2017.09.040","article-title":"Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum \u2012 A retrospective analysis","volume":"78","author":"Xia","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2016.05.044","article-title":"Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: the Mayo Clinic experience, 1996 through 2013","volume":"75","author":"Barbosa","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2022.08.005_bib0110","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/jid.2012.130","article-title":"Incidence, mortality, and disease associations of pyoderma gangrenosum in the united kingdom: a retrospective cohort study","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum","volume":"13","author":"Ahronowitz","year":"2012","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jaad.2009.05.030","article-title":"Pyoderma gangrenosum: a review and update on new therapies","volume":"62","author":"Miller","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut."},{"key":"10.1016\/j.abd.2022.08.005_bib0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2230.2008.02706.x","article-title":"Subcorneal pustular dermatosis: 50 years on","volume":"33","author":"Cheng","year":"2008","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0738-081X(99)00123-6","article-title":"Neutrophilic eccrine hidradenitis","volume":"18","author":"Bachmeyer","year":"2000","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0140","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1346-8138.14916","article-title":"Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy","volume":"46","author":"Sato\u2010Sano","year":"2019","journal-title":"J Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0145","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/263827","article-title":"Eosinophilic panniculitis and insect bite-like eruption in a patient with chronic lymphocytic leukaemia: a spectrum of the same entity","volume":"2010","author":"Rodr\u00edguez-Lojo","year":"2010","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.abd.2022.08.005_bib0150","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1600-0560.2012.01906.x","article-title":"Eosinophilic dermatosis of hematologic malignancy","volume":"39","author":"Farber","year":"2012","journal-title":"J Cut Pathol."},{"key":"10.1016\/j.abd.2022.08.005_bib0155","first-page":"1378","article-title":"Eosinophilic dermatosis of myeloproliferative disease: characterization of a unique eruption in patients with hematologic disorders","volume":"137","author":"Byrd","year":"2001","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0160","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.ad.2016.10.021","article-title":"Dermatosis eosinof\u00edlicas asociadas a procesos hematol\u00f3gicos","volume":"108","author":"Lucas-Truyols","year":"2017","journal-title":"Actas Dermo-Sifiliograf."},{"key":"10.1016\/j.abd.2022.08.005_bib0165","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jdcr.2019.07.026","article-title":"Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia","volume":"5","author":"Jin","year":"2019","journal-title":"JAAD Case Reports"},{"key":"10.1016\/j.abd.2022.08.005_bib0170","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.clindermatol.2019.07.031","article-title":"Pruritus as a sign of systemic disease","volume":"37","author":"Welz-Kubiak","year":"2019","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/bjd.16117","article-title":"British Association of Dermatologists\u2019 guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018","volume":"178","author":"Millington","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0180","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ajh.23474","article-title":"Aquagenic pruritus in polycythemia vera: characteristics and influence on quality of life in 441 patients","volume":"88","author":"Siegel","year":"2013","journal-title":"Am J Hematol."},{"key":"10.1016\/j.abd.2022.08.005_bib0185","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232480","article-title":"Intractable pruritus in chronic myelomonocytic leukaemia and myelodysplastic syndromes: a case series","volume":"12","author":"Ceesay","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.abd.2022.08.005_bib0190","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2340\/00015555-2906","article-title":"Aquagenic pruritus in polycythemia vera: clinical characteristics","volume":"98","author":"Lelonek","year":"2018","journal-title":"Acta Dermato-Venereol."},{"key":"10.1016\/j.abd.2022.08.005_bib0195","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00277-016-2674-2","article-title":"Pruritus in primary myelofibrosis: management options in the era of JAK inhibitors","volume":"95","author":"Vaa","year":"2016","journal-title":"Ann Hematol."},{"key":"10.1016\/j.abd.2022.08.005_bib0200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajh.22215","article-title":"Pruritus in primary myelofibrosis: clinical and laboratory correlates","volume":"87","author":"Vaa","year":"2012","journal-title":"Am J Hematol."},{"key":"10.1016\/j.abd.2022.08.005_bib0205","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1111\/jdv.16370","article-title":"Aprepitant in refractory pruritus of systemic lymphoproliferative disorders","volume":"34","author":"Pulido-Perez","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2022.08.005_bib0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.medcli.2019.10.004","article-title":"Chronic prurigo as a onset of Hodgkin\u2019s lymphoma","volume":"156","author":"Serra-Garc\u00eda","year":"2021","journal-title":"Med Cl\u00edn."},{"key":"10.1016\/j.abd.2022.08.005_bib0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000489161","article-title":"Chronic prurigo: an unusual presentation of Hodgkin lymphoma","volume":"10","author":"Dumont","year":"2018","journal-title":"Case Rep Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0220","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1525-1470.1990.tb00670.x","article-title":"Hodgkin\u2019s disease manifesting as prurigo nodularis","volume":"7","author":"Shelnitz","year":"1990","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0225","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/ijd.12022","article-title":"Prurigo nodularis as index symptom of (non-Hodgkin) lymphoma: ultrasound as a helpful diagnostic tool in dermatological disorders of unknown origin","volume":"54","author":"Schweda","year":"2015","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1067\/mjd.2000.105502","article-title":"Adult-onset recalcitrant eczema: a marker of noncutaneous lymphoma or leukemia","volume":"43","author":"Callen","year":"2000","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0235","first-page":"63","article-title":"Systemic vasculitis in myelodysplastic syndromes","volume":"70","author":"Oostvogels","year":"2012","journal-title":"Neth J Med."},{"key":"10.1016\/j.abd.2022.08.005_bib0240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MD.0000000000000009","article-title":"The spectrum of paraneoplastic cutaneous vasculitis in a defined population","volume":"92","author":"Loricera","year":"2013","journal-title":"Medicine."},{"key":"10.1016\/j.abd.2022.08.005_bib0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.semdp.2019.01.001","article-title":"Cutaneous paraneoplastic syndromes","volume":"36","author":"Wick","year":"2019","journal-title":"Sem Diagn Pathol."},{"key":"10.1016\/j.abd.2022.08.005_bib0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00128071-200809020-00001","article-title":"Clinical approach to cutaneous vasculitis","volume":"9","author":"Chen","year":"2008","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000081475","article-title":"Cutaneous vasculitis in the course of hematologic malignancies","volume":"210","author":"Bachmeyer","year":"2005","journal-title":"Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0260","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/ijd.14169","article-title":"Erythema elevatum diutinum: a case report and review of literature","volume":"58","author":"Doktor","year":"2019","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0738-081X(99)00120-0","article-title":"Erythema elevatum diutinum","volume":"18","author":"Gibson","year":"2000","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0190-9622(92)70003-X","article-title":"Erythema elevatum diutinum: a clinical and histopathologic study of 13 patients","volume":"26","author":"Yiannias","year":"1992","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0275","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/jdv.12566","article-title":"Erythema elevatum diutinum: a review of presentation and treatment","volume":"28","author":"Momen","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2022.08.005_bib0280","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic Pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Eng J Med."},{"key":"10.1016\/j.abd.2022.08.005_bib0285","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/ijms18122532","article-title":"Paraneoplastic emphigus: insight into the autoimmune pathogenesis, clinical features and therapy","volume":"18","author":"Paolino","year":"2017","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.abd.2022.08.005_bib0290","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.autrev.2018.04.008","article-title":"Paraneoplastic autoimmune multiorgan syndrome (PAMS): beyond the single phenotype of paraneoplastic pemphigus","volume":"17","author":"Amber","year":"2018","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.abd.2022.08.005_bib0295","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-4632.2009.03995.x","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome","volume":"48","author":"Sehgal","year":"2009","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0300","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-4362.2001.01169.x","article-title":"Paraneoplastic pemphigus","volume":"40","author":"Kimyai-Asadi","year":"2001","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0305","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0923-1811(94)00371-K","article-title":"The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan","volume":"9","author":"Ogawa","year":"1995","journal-title":"J Dermatol Sci."},{"key":"10.1016\/j.abd.2022.08.005_bib0310","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3390\/ijms21062178","article-title":"Paraneoplastic dermatoses: a brief general review and an extensive analysis of paraneoplastic pemphigus and paraneoplastic dermatomyositis","volume":"21","author":"Didona","year":"2020","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.abd.2022.08.005_bib0315","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40257-016-0235-z","article-title":"Paraneoplastic pemphigus and autoimmune blistering diseases associated with neoplasm: characteristics, diagnosis, associated neoplasms, proposed pathogenesis, treatment","volume":"18","author":"Kartan","year":"2017","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<58::AID-AJH10>3.0.CO;2-3","article-title":"Paraneoplastic pemphigus in a patient with non-Hodgkin\u2019s lymphoma","volume":"52","author":"Plumb","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.abd.2022.08.005_bib0325","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199905063401805","article-title":"The mechanism of respiratory failure in paraneoplastic pemphigus","volume":"340","author":"Nousari","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.abd.2022.08.005_bib0330","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic pemphigus","volume":"9","author":"Anhalt","year":"2004","journal-title":"J Invest Dermatol Symp Proc."},{"key":"10.1016\/j.abd.2022.08.005_bib0335","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-4632.2011.04868.x","article-title":"Paraneoplastic autoimmune multiorgan syndrome: 20 years after","volume":"50","author":"Czernik","year":"2011","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0340","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaad.2006.04.047","article-title":"Acquired ichthyosis","volume":"55","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0345","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jamadermatol.2020.1081","article-title":"Acquired ichthyosis in a middle-aged woman","volume":"156","author":"Saardi","year":"2020","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0350","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40257-021-00592-w","article-title":"Erythema nodosum: a practical approach and diagnostic algorithm","volume":"22","author":"P\u00e9rez-Garza","year":"2021","journal-title":"Am J Clinl Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0355","doi-asserted-by":"crossref","first-page":"e8666","DOI":"10.1097\/MD.0000000000008666","article-title":"Acute myeloid leukemia presenting as erythema nodosum","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine."},{"key":"10.1016\/j.abd.2022.08.005_bib0360","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1200\/JCO.2007.12.0022","article-title":"Presentation of childhood acute myeloid leukemia with erythema nodosum","volume":"25","author":"la Spina","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.abd.2022.08.005_bib0365","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-229164","article-title":"Diffuse plane xanthoma developing in association with prior monoclonal gammopathy","volume":"12","author":"Falk","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.abd.2022.08.005_bib0370","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1590\/S0365-05962010000100010","article-title":"Diffuse plane idiopathic normolipemic xanthoma with hiperesplenism","volume":"85","author":"da","year":"2010","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0375","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5507\/bp.2014.016","article-title":"Xanthomas: clinical and pathophysiological relations","volume":"158","author":"Zak","year":"2014","journal-title":"Biomed Papers."},{"key":"10.1016\/j.abd.2022.08.005_bib0380","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamadermatol.2020.0897","article-title":"Necrobiotic xanthogranuloma","volume":"156","author":"Dellatorre","year":"2020","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0385","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jdv.13786","article-title":"Treatment of necrobiotic xanthogranuloma \u2012 a systematic review","volume":"31","author":"Miguel","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2022.08.005_bib0390","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/bjh.17300","article-title":"Necrobiotic xanthogranuloma in IgG\u2010\u03ba multiple myeloma","volume":"193","author":"Giacalone","year":"2021","journal-title":"Br J Haematol."},{"key":"10.1016\/j.abd.2022.08.005_bib0395","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.mayocp.2021.05.012","article-title":"Necrobiotic xanthogranuloma","volume":"96","author":"Portuguese","year":"2021","journal-title":"Mayo Clin Proceed."},{"key":"10.1016\/j.abd.2022.08.005_bib0400","first-page":"126","article-title":"Necrobiotic xanthogranuloma \u2012 case report and literature review","volume":"47","author":"Geoloaica","year":"2021","journal-title":"Curr Health Sci J."},{"key":"10.1016\/j.abd.2022.08.005_bib0405","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jdcr.2022.01.008","article-title":"Necrobiotic xanthogranuloma with type 1 cryoglobulinemia mimicking necrobiosis lipoidica in a young woman with myeloma","volume":"21","author":"Means","year":"2022","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.abd.2022.08.005_bib0410","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5021\/ad.2020.32.1.53","article-title":"Necrobiotic xanthogranuloma coexists with diffuse normolipidemic plane xanthoma and multiple myeloma","volume":"32","author":"Kim","year":"2020","journal-title":"Ann Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0415","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/jdv.14466","article-title":"European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: scleromyxedema, scleredema and nephrogenic systemic fibrosis","volume":"31","author":"Knobler","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2022.08.005_bib0420","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jaad.2007.04.033","article-title":"Scleromyxedema","volume":"57","author":"Heymann","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0425","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaad.2013.01.007","article-title":"Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients","volume":"69","author":"Rongioletti","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.08.005_bib0430","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.seminoncol.2016.02.017","article-title":"Cutaneous manifestations of multiple myeloma and other plasma cell proliferative disorders","volume":"43","author":"Bhutani","year":"2016","journal-title":"Semin Oncol."},{"key":"10.1016\/j.abd.2022.08.005_bib0435","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13378","article-title":"Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin","volume":"33","author":"Kim","year":"2020","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.abd.2022.08.005_bib0440","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/ijd.14888","article-title":"Scleromyxedema treatment: a systematic review and update","volume":"59","author":"Haber","year":"2020","journal-title":"Int J Dermatol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622002914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622002914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:40:51Z","timestamp":1759794051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059622002914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0365059622002914"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2022.08.005","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatological manifestations of hematologic neoplasms. Part II: nonspecific skin lesions\/paraneoplastic diseases","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2022.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedade Brasileira de Dermatologia.","name":"copyright","label":"Copyright"}]}}